Rallybio Corporation / Fundamentals

    Income statement

    Net revenue
    €652.94K
    Cost of goods sold
    €0.00
    Gross profit
    €627.20K
    SG&A expenses
    €14.36M
    R&D expenses
    €23.50M
    EBITDA
    -€37.16M
    D&A
    €99.53K
    EBIT
    -€37.24M
    Interest expenses
    €0.00
    EBT
    -€35.74M
    Tax expenses
    -€122.69K
    Net income
    -€35.74M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €1.36M
    Changes in working capital
    -€8.17M
    Operating cash flow
    -€36.03M
    Capex
    €0.00
    Other investing cash flow
    -€4.29M
    Net investing cash flow
    €29.81M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€4.45M
    Debt repayment
    €0.00
    Other financing cash flow
    €6.01K
    Net financing cash flow
    €14.59K
    Foreign exchange effects
    €0.00
    Net change in cash
    -€6.20M
    Cash at end of period
    €8.10M
    Free cash flow
    -€36.03M

    Balance sheet

    Cash and cash equivalents
    €8.10M
    Cash and short-term investments
    €39.25M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.87M
    Total current assets
    €43.13M
    Property, plant & equipment
    €96.10K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €537.11K
    Other non-current assets
    €0.00
    Total non-current assets
    €633.20K
    Total assets
    €43.76M
    Accounts payable
    €102.10K
    Short-term debt
    €49.76K
    Other current liabilities
    €3.63M
    Total current liabilities
    €4.32M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €4.32M
    Common stock
    €3.43K
    Retained earnings
    -€267.84M
    Other equity
    €14.59K
    Total equity
    €39.44M
    Total liabilities and shareholders' equity
    €43.76M

    Company information

    Market capitalization
    €11.81M
    Employees
    25
    Enterprise Value
    -€268.72K

    Company ratios

    Gross margin
    96.1% Much better than peer group: 69.3%
    EBITDA margin
    -5,691.3% Much worse than peer group: -452.1%
    EBIT margin
    -5,703.2% Much better than peer group: -7,985.0%
    EBT margin
    -5,473.3% Much better than peer group: -404,034.0%
    Net margin
    -5,473.3% Much worse than peer group: 3,600.1%
    ROE
    -90.6% Much worse than peer group: -12.2%
    ROA
    -81.7% Much worse than peer group: -30.4%
    Asset turnover
    1.5% Much worse than peer group: 56.3%
    FCF margin
    -5,517.9% Much better than peer group: -21,344.5%
    FCF yield
    -305.2%
    Efficiency ratio
    5,791.3%
    Net sales per employee
    €26.12K
    Net income per employee
    -€1.43M

    Notifications